Capricor: Moving To 'Buy' Rating As New PDUFA Date Is Set For Deramiocel

Core Insights - The article emphasizes the value of in-depth analysis in the Biotech sector, highlighting the services offered by Biotech Analysis Central, which includes a library of over 600 articles and a model portfolio of small and mid-cap stocks [2] Group 1 - The Biotech Analysis Central service is available for $49 per month, with a discounted annual plan at $399, representing a 33.50% savings for subscribers [1] - The service aims to assist healthcare investors in making informed decisions through comprehensive analysis and news reports [2] - The author has a background in Applied Science, which is leveraged to generate long-term value in the healthcare sector [2]